Wishing you a joyful and relaxing holiday season from all of us at Kenai Therapeutics!

We’re heading to San Francisco next month!
Our CEO Nick Manusos will be speaking at the Sachs Associates Neuroscience Innovation Forum #Sachs_NIF. Later that week, our team will be attending the #JPMHealthcareConference. We look forward to catching up with partners and familiar faces!

We dosed the first patient in our Phase 1 REPLACE trial evaluating RNDP-001, a neuron replacement cell therapy for idiopathic #ParkinsonsDisease. RNDP-001 also received #FDA #FastTrackDesignation. Learn more: bit.ly/4qdLUe0

Our CEO Nick Manusos had the opportunity to speak at the Cell & Gene Meeting on the Mesa, where he shared insights into our #iPSC platform and lead candidate for the treatment of #ParkinsonsDisease. Thank you to the Alliance for Regenerative Medicine for another wonderful meeting! #CGMesa25

We are a proud sponsor of the Parkinson's Foundation's #MovingDay! Our team walked alongside patients, caregivers and loved ones to raise awareness and funds for Parkinson's research in Chicago and LA. We're grateful to be part of such an inspiring day and community!

Attending the Alliance for Regenerative Medicine’s 2025 Cell & Gene Meeting on the Mesa? If so, be sure to join CEO Nick Manusos on Tuesday 10/7 at 2pm for Kenai's company presentation. Explore the full agenda here: meetingonthemesa.com

#CGMesa25 #celltherapy @alliancerm.bsky.social

We had the pleasure of hosting an inspiring group of students for Generation STEAM's #GirlsWhoLead program! The day included a lab tour, conversations about the R&D process and stories from our team about their career paths. We’re proud to support the next generation of women leaders in #biotech!

The #ChicagoBioLifeSummit last week was an inspiring gathering of industry leaders and #innovators! Nick Manusos, Kenai's CEO, joined an insightful panel of life science experts to discuss how to navigate the investment landscape. Thanks to BioLife Summits for organizing this engaging conversation!

The #ChicagoBioLifeSummit is taking place tomorrow, May 28th in downtown Chicago! Our CEO Nick Manusos will be joining a panel of #LifeSciences industry experts at 2:25 pm to discuss successfully navigating the investment landscape.

View the full agenda and register here:
lnkd.in/eyHFy4v4

Join Dr. Howard Federoff, Kenai's CMO, at the 2nd Global Cell & Gene Therapy Summit, July 7–9 in Orlando!

His session will include a panel discussion on advances in cell and stem cell-based therapies. Learn more and register here: cgtsummit.unitedscientificgroup.org

#CGTSummit2025 #CellTherapy

April is #ParkinsonsAwarenessMonth 💙 We’re committed to bringing hope to people living with Parkinson's disease through science, partnership and purpose. 🤝 Join us in raising awareness and supporting the PD community: www.michaeljfox.org/parkinsons-awareness-month

Congratulations to Derek Hei on being honored with the International Society for Stem Cell Research's public service award! This award recognizes Derek's commitment to advancing stem cell science and regenerative medicine. Learn more about the award and ISSCR's work: bit.ly/3XDUqXV